Ayushi Hemantbhai Patel

Ayushi Hemantbhai Patel

Active Director Director DIN 08070864
DIN 08070864 First appointment Jan 2018 Primary industry Healthcare
Unlock full profile Investments Β· shareholding Β· contact details
Current companies 1 active board seats
Total affiliations 1 Since Jan 2018
Shareholding value β€’β€’β€’β€’ Premium profile

About Ayushi Hemantbhai Patel

Data last updated:

Ayushi Hemantbhai Patel is a Director at Gita Mediquip Private Limited (since 2018). The company operates in Healthcare.

DIN 08070864
Primary Designation Director
Industry Healthcare
First Appointment 27 Jan 2018
Oldest Company Age 12 yrs

Current companies

CompanyDesignationAppointmentFoundedRevenueStatus
Gita Mediquip Private Limited U36941GJ2014PTC079477
Director27 Jan 20182014Active

Directorship timeline

Open interactive timeline →
Gita Mediquip Private Limited
Premium access

Shareholding and investment profile for Ayushi Hemantbhai Patel

Company-level share counts, filed values, and quarterly changes require authenticated premium access.

  • Company-level holdings
  • Filed share counts
  • Reported values
  • Quarterly changes
Unlock shareholding

Verified entity values are shown only after access is granted.

Frequently Asked Questions about Ayushi Hemantbhai Patel

Ayushi Hemantbhai Patel currently holds 1 directorship: Gita Mediquip Private Limited (Director, since 27 Jan 2018).

Ayushi Hemantbhai Patel was first appointed on 27 Jan 2018 as Director at Gita Mediquip Private Limited.

The current boards of Ayushi Hemantbhai Patel's companies include Alkaben Hemantkumar Patel (Gita Mediquip Private Limited), Harpal Hemantbhai Patel (Gita Mediquip Private Limited), Hemant Ambalal Patel (Gita Mediquip Private Limited), Vikram Mangaldas Panchal (Gita Mediquip Private Limited).

Explore millions of companies β€” effortlessly

Access structured, verified intelligence on 7M+ companies across industries, sectors, and global markets. From early-stage startups to large enterprises, discover ownership, leadership, funding, financials, acquisitions, and market signals β€” all in one powerful platform.

Free account with essential features Instant access to company reports Enterprise solutions available